RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • 비소세포암에서 C-erbB-2와 COX-2 발현의 면역조직화학적 관련성

        유승진 중앙대학교 의과대학 의과학연구소 2010 中央醫大誌 Vol.35 No.1/2

        Background & Purpose: The study for inhibitors of gene products participating in multistep carcinogenetic event of human cancer is important target relevant to chemoprevention or adjuvant therapy of cancer. This study was performed to search basic data for chemoprevention or adjuvant therapy of human non-small cell lung cancer and to evaluate coexpression of each gene product, the relationship between the expression of each gene product and clinicopathologic factor or prognosis. Method: The following formalin-fixed paraffin embedded surgical specimen was immunohistochemically stained by avidin-biotin complex method for C-erbB-2 and COX-2; 55 cases of squamous cell carcinoma and 29 cases of adenocarcinoma of lung. Results: Positive C-erbB-2 and COX-2 expression is more often seen in adenocarcinoma compared with squamous cell carcinoma. Correlation between early and advanced cancer was insignificant. Coexpression of C-erbB-2 and COX-2 expression is more often seen in adenocarcinoma compared with squamous cell carcinoma. Conclusion: These results suggested that degree of C-erbB-2 and COX-2 expression depended upon histologic type of non-small cell lung cancer. However, further studies are required for the determination of significant relationship in coexpression of two gene products and clinicopathologic indices.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼